Drugs / Trimethoprim/sulfamethoxazole
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT01049633 Background | — | type 1 diabetes mellitus | National Institute of Allergy and Infectious Diseases (NIAID) | No longer available | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trimethoprim/sulfamethoxazole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01049633 ↗ |
| Route | Oral | “80mg/400mg by mouth once a day” NCT01049633 ↗ |